Anatara Lifesciences Ltd (ASX:ANR) PAC Partners Equity Research Report

🕔1/15/2019 12:31:24 PM

PAC Partners Equity Research has released its latest research and valuation report on Anatara Lifesciences (ASX:ANR). The report provided a BUY rating and a 12-month price target of $1.40 per share.

Read Full Article

Queensland Bauxite Ltd (ASX:QBL) ASX Approval Letter and Terms of ASX Waivers

🕔1/14/2019 3:49:35 PM

Queensland Bauxite Limited (ASX:QBL) is most pleased to announce that the Company has received the formal approval letter for its application for reinstatement to the official list of ASX Limited.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Receives $1.249m R&D Tax Refund

🕔1/14/2019 8:39:28 AM

Anatara Lifesciences (ASX:ANR) is pleased to announce that it has received $1,249,299 from the Australian Taxation Office under the Federal Government's Research and Development Tax Incentive scheme.

Read Full Article

Oventus Medical Ltd (ASX:OVN) New Nylon O2Vent Optima Oral Device Launched in Australia

🕔1/8/2019 10:36:18 AM

Oventus Medical Ltd (ASX:OVN) is pleased to announce the launch of the O2Vent(R) Optima device in Australia, an important addition to the Company's sleep treatment platform.

Read Full Article

Regeneus Ltd (ASX:RGS) Chinese Patent Granted for Biomarkers for Stem Cell Therapy

🕔12/3/2018 9:34:26 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce the State Intellectual Property Office of China has granted the Company a patent for the use of biomarkers to monitor disease progression in a patient having mesenchymal cell therapy for inflammatory conditions.

Read Full Article

Regeneus Ltd (ASX:RGS) Chairman's Address to Shareholders

🕔11/22/2018 2:06:22 PM

Regeneus Ltd (ASX:RGS) provides the Company's Chairman Address to Shareholders.

Read Full Article

Oventus Medical Ltd (ASX:OVN) 2018 AGM Presentation

🕔11/16/2018 12:12:19 PM

Oventus Medical Ltd (ASX:OVN) provides the Company's 2018 AGM Presentation.

Read Full Article